| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3391242 | Seminarios de la Fundación Española de Reumatología | 2008 | 12 Pages |
Abstract
Little has changed in the treatment of myositis and this entity continues to be treated with high-dose corticosteroids. However, increasing insight into the pathophysiology of myositis, as well as carefully designed multicenter clinical trials, should result in better therapeutic strategies and recommendations in the future.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
M. Cristina López Sánchez, Natalia Palmou Fontana, José A. Pinto Tasende,